IL22 and liver disorder: Despite the clear evidence from animal models, we do not yet know to what extent IL-22 secreting T cells participate in different stages of human liver disease, their impact in tissue, or to what extent measurement of such cells in blood or liver may vary or correlate with clinical outcome.